Skip to main content

SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC

Brooklyn, NYEIN: 11-3106037

Data sourced from IRS 990 public filings

SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC To improve the quality of life for individuals and families living with sickle cell disease, and other inherited blood disorders.

SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC has received 2 grants from 2 known foundation funders. Revenue increased from $262,347 in 2023 to $483,355 in 2024. Most recent reported revenue: $483,355.

Annual Revenue

$483,355

Known Funders

2

Grants Received

2

Financial History

YearRevenueExpensesAssets
2024$483,355$483,415$66,890
2023$262,347$249,880$12,769
2022$421,315$484,025$45,761
2021$301,033$219,856$127,418
2020$245,519$203,218$127,376
2019$226,614$219,662$124,572
2018$248,103$209,404$126,619
2017$188,534$163,543$157,216

Top Funders

$3,000 (2021)
$110 (2023)

Key Personnel

From 2024 IRS 990 filing

V

VIVIAN OKWUAGWU

SECRETARY

Officer
T

TERESA DAVIS

PRESIDENT

Officer

Frequently Asked Questions

Other Nonprofits in New York

All nonprofits in New York

Unlock Full Nonprofit Data

Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.

Unlock full data & AI matching Sign up free

    SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC (EIN: 11-3106037) - Funders & 990 Data | Signal990